Recently, we showed that hypoxia induction and macrophage migration inhibitory (MIF) modification could improve the therapeutic effects of MSC-derived exosomes in myocardial infarction (MI) by inhibiting apoptosis and promoting angiogenesis [14]. This evidence concerns the gene MIF and myocardial infarction.